Healwell AI Inc. (TSX:AIDX)

Market Cap	356.17M
Revenue (ttm)	48.48M
Net Income (ttm)	-34.12M
Shares Out	276.10M
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	170,860
Average Volume	261,591
Open	1.280
Previous Close	1.290
Day's Range	1.240 - 1.320
52-Week Range	1.090 - 2.360
Beta	-1.04
RSI	42.77
Earnings Date	Aug 12, 2025

About Accolade

Healwell AI Inc., a healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom. The company operates through three segments: Clinical Research and Patient services, AI and Data Sciences, and Healthcare Software. It also provides AI-driven healthcare information analytics and insights, technology-enabled chronic disease screening, electronic health record software and healthcare data management services, pulmonary function testing lab service...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2012
• Employees: 350
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: AIDX

Financial Performance

In 2024, Healwell AI's revenue was 38.97 million, an increase of 432.62% compared to the previous year's 7.32 million. Losses were -26.29 million, -16.79% less than in 2023.